drugset

drugset / Trial / NCT06001853

Allogeneic BM-MSCs in Patients With Painful Lumbar Facet Arthropathy

NCT06001853 ↗

Phase 2 Active not recruiting 40 enrolled Mayo Clinic

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this research study is to evaluate the safety and effect of bone marrow-derived stem cells for the treatment of low back pain.

Timeline

Start: 2023-11-03
Primary completion: 2027-12
Completion: 2027-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	BM-MSCs	Cell therapy	1e+07 cells	Other

Indications